Immune checkpoint inhibitors (ICIs) have revolutionized the care of patients with cancer, but use among hospitalized patients is controversial as a result of questionable benefit and high costs. To ...
Objective Systemic lupus erythematosus (SLE) is associated with increased susceptibility to infections, including herpes ...